CRITICAL SUCCESS FACTORS IN UNIVERSITY-INDUSTRY COLLABORATION
Tuesday, 5 MAY 2015 @ 6.00pm CET
Moderator: Tatiana Schofield, Managing Director, Synergy lab
TALK 1: THE ROLE OF ACADEMIC TECHNOLOGY IN THE PHARMACEUTICAL INDUSTRY
In the US, the largest share of federal funding for university research comes from the National Institutes of Health (NIH). Since invention follows research funding in a fairly linear manner, it is perhaps not surprising that some of the biggest impacts of academic research on the economy have been in healthcare. We will look at the role of universities in the transformation of Boston into the center of world pharmaceutical research, of the contribution of public sector research in the discovery of marketed new drugs, and of the role of academic medicine in the invention of medical devices
ASHLEY J STEVENS DPHIL (OXON), CLP, RTTP
PRESIDENT, FOCUS IP GROUP, LLC
Before founding Focus IP Group, LLC, an intellectual property consulting company, he was Executive Director of the technology transfer office at Boston University for seventeen years. He is a lecturer in the Health Sector Management Program in BU’s School of Management, where he teaches Bench-to-Bedside, a graduate-level, inter-disciplinary course on Technology Commercialization, and he teaches an intensive version of this course, G-TEC, at Osaka University each summer. He is a Principal Investigator at the National University of Singapore (Suzhou) Research Institute, where he teaches professional development courses in technology management. Prior to joining Boston University, he was Director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School. Before entering the technology transfer profession, Dr Stevens worked in the biotechnology industry for nearly ten years and founded two biotechnology companies, and has helped spin-out over sixty companies from Dana-Farber and Boston University. He is a Past President of AUTM, and has written and lectured extensively on many aspects of technology transfer.
Dr Stevens holds a BA in Natural Sciences, an MA and a DPhil in Physical Chemistry from Oxford University. He is a Certified Licensing Professional and a Registered Technology Transfer Professional.
During this one-hour webinar, we will look into a wider spectrum of knowledge transfer between academia and industry. Research commercialisation is more than licensing and spin-offs. The webinar will look specifically into university-industry collaboration, presenting two examples of such partnerships and their role in driving innovation.
TALK 2: ACADEMIC-INDUSTRY CONSORTIA
Commercialisation is far more than filing patents, licensing and spin-outs – the traditional Technology Transfer model. It is the entire academic-industry relationship ranging from traditional technology transfer through research collaboration, consultancy, to student-industry interaction. Arguably the traditional model is the least effective in transferring the results of publically funded research to the market place for societal, economic and financial benefit. Recently both the UK and Dutch governments published their strategy/vision on publically funded research for the coming years. Strongly featured in both was the need for greater academic-industry interaction to optimize the benefits from the public research base. This presentation will focus on academic-industry research collaboration, particularly consortia. Two different but highly successful consortia will be used to illustrate what can be achieved. Can we go further, giving access directly to institution’s research results even at a prepublication phase? What are the risks and benefits? Is there really a financial loss incurred, or are these outweighed by wider benefits and compliance with government wishes which ultimately pays for (most of) the research.
Dr Bob Smailes
Partner, Gunn and Twynmore
Bob Smailes has twenty-six years’ experience in establishing and heading Research and Technology Transfer Offices in all scientific areas in both the UK and the Netherlands. He has extensive knowledge in company formation, licensing, and a wide knowledge of Intellectual Property Rights. He is widely experienced in working with universities, government agencies, multi nationals and SMEs. Prior to the university sector, he worked in chemical and material science industries in research, marketing, and strategic planning roles. He has a PhD in Chemistry and his MBA dissertation was on the motivation of academics in research.
REGISTRATION FEE: 50€ – which includes access to the webinar and annual THA regular individual membership. If you are interested in the THA webinar series, the annual THA regular organizational membership (200€) includes free access to all six titles.
THA members can join the webinar free of charge
To register please email: *email address protected*
Video recordings of the previous titles From the ivory tower to the Entrepreneurial University and University Rankings, the Triple Helix Model and Webometrics: Opening Pandora’s Box are available for THA members at our webpage www.triplehelixassociation.org in the TH repository.